<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: adhesion molecule</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Scientists identify important regulator for synapse stability and plasticity</title>
   	 <description>(Medical Xpress)—Using the fruit fly as a model organism, neurobiologists from the Friedrich Miescher Institute for Biomedical Research have identified the L1-type CAM neuroglian as an important regulator for synapse growth, function and stability. They show that the interaction of neuroglian with ankyrin provides a regulatory module to locally control synaptic connectivity and function.</description>
     <link>http://medicalxpress.com/news/2013-04-scientists-important-synapse-stability-plasticity.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 25 Apr 2013 07:59:47 EST</pubDate>
	 <guid isPermaLink="false">news286095579</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/fmiscientist.jpg" width="90" height="90" />
</item>
<item>
     <title>Signature of circulating breast tumor cells that spread to the brain found</title>
   	 <description>Some breast tumor circulating cells in the bloodstream are marked by a constellation of biomarkers that identify them as those destined to seed the brain with a deadly spread of cancer, said researchers led by those at Baylor College of Medicine in a report that appears online in the journal Science Translational Medicine.</description>
     <link>http://medicalxpress.com/news/2013-04-signature-circulating-breast-tumor-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 10 Apr 2013 14:00:02 EST</pubDate>
	 <guid isPermaLink="false">news284818141</guid>
	 
</item>
<item>
     <title>High hsCRP may up risk of macular edema in T1DM</title>
   	 <description>(HealthDay)—For patients with type 1 diabetes mellitus, elevated levels of high-sensitivity C-reactive protein (hsCRP) are associated with an increased risk of clinically significant macular edema (CSME) and with the development of retinal hard exudates, according to a study published online Feb. 7 in JAMA Ophthalmology.</description>
     <link>http://medicalxpress.com/news/2013-02-high-hscrp-macular-edema-t1dm.html</link>
	 <category>Ophthalmology</category>
	 <pubDate>Fri, 08 Feb 2013 14:10:01 EST</pubDate>
	 <guid isPermaLink="false">news279552940</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/highhscrpmay.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists identify new target for lung cancer treatment</title>
   	 <description>A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time. The findings will be published in the November issue of Cancer Research.</description>
     <link>http://medicalxpress.com/news/2012-11-scientists-lung-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 01 Nov 2012 15:11:39 EST</pubDate>
	 <guid isPermaLink="false">news271001442</guid>
	 
</item>
<item>
     <title>Hunting for the last remaining tumour cell</title>
   	 <description>The 7.5 millilitres of blood contained in a standard sample tube is not nearly enough to detect circulating tumour cells (CTCs) in the blood of patients with metastatic breast cancer, prostate cancer, or colorectal cancer with a high enough degree of reliability. These CTCs are the cause of metastases in cancer patients. If they can be effectively characterized, it is possible to arrive at a prognosis and to determine the most effective course of treatment. However, the only way to detect &quot;that one particular cell&quot; is to subject the patient's entire blood volume to a kind of dialysis. This was the conclusion reached by Dr Frank Coumans in an article published in the journal Clinical Cancer Research. Dr Coumans works at the University of Twente's MIRA Institute for Biomedical Technology and Technical Medicine. He was recently awarded a PhD (with distinction) on this topic.</description>
     <link>http://medicalxpress.com/news/2012-10-tumour-cell.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 29 Oct 2012 10:10:03 EST</pubDate>
	 <guid isPermaLink="false">news270723176</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/57-clipboard-1.jpg" width="90" height="90" />
</item>
<item>
     <title>Potential new colorectal cancer treatment target identified</title>
   	 <description>(HealthDay)—The cell surface marker carcinoembryonic antigen-related cell adhesion molecule 6 (CD66c) is a novel marker for colorectal cancer stem cell isolation, which halts tumor growth when silenced, according to research published online Oct. 1 in Cancer.</description>
     <link>http://medicalxpress.com/news/2012-10-potential-colorectal-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 07 Oct 2012 14:14:26 EST</pubDate>
	 <guid isPermaLink="false">news268838053</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-potentialnew.jpg" width="90" height="90" />
</item>
<item>
     <title>Immune system compensates for 'leaky gut' in inflammatory bowel disease susceptibility</title>
   	 <description>New research could clarify how inflammatory bowel diseases (IBD), conditions that include ulcerative colitis and Crohn's disease, are triggered and develop.</description>
     <link>http://medicalxpress.com/news/2012-09-immune-compensates-leaky-gut-inflammatory.html</link>
	 <category>Immunology</category>
	 <pubDate>Thu, 13 Sep 2012 12:56:26 EST</pubDate>
	 <guid isPermaLink="false">news266759776</guid>
	 
</item>
<item>
     <title>Behavioral test shows promise in predicting future problems with alcohol</title>
   	 <description>(Medical Xpress)—By administering a simple behavioral test, Yale researchers were able to predict which mice would later exhibit alcoholism-related behaviors such as the inability to stop seeking alcohol and a tendency to relapse, the scientists report in the Aug. 26 issue of the journal Nature Neuroscience.</description>
     <link>http://medicalxpress.com/news/2012-08-behavioral-future-problems-alcohol.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 27 Aug 2012 08:29:22 EST</pubDate>
	 <guid isPermaLink="false">news265274950</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/shutterstock_46210036.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers discover that JAM-A protein keeps blood clots in check</title>
   	 <description>those disc-shaped cells circulating in your blood -- rush to the scene, clumping together to plug the leak.</description>
     <link>http://medicalxpress.com/news/2012-05-jam-a-protein-blood-clots.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 03 May 2012 11:00:01 EST</pubDate>
	 <guid isPermaLink="false">news255260481</guid>
	 
</item>
<item>
     <title>Outwitting a brainy gene</title>
   	 <description>(Medical Xpress) -- The very first in the series of mutations causing colon cancer occurs in the beta-catenin gene; this gene is abnormally activated in about 90 percent of colorectal cancer patients, and in a much smaller percentage of people with almost every other type of cancer. Beta-catenin plays a dual role in the cell: it promotes adhesion, or stickiness, between cells, and regulates the expression of genes in the nucleus.</description>
     <link>http://medicalxpress.com/news/2012-05-outwitting-brainy-gene.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 01 May 2012 10:40:01 EST</pubDate>
	 <guid isPermaLink="false">news255084489</guid>
	 
</item>
<item>
     <title>Radioactive antibody fragment may help scientists identify artery deposits</title>
   	 <description>Creating a radioactive antibody fragment may allow scientists to identify fat and debris deposits in artery walls that are most likely to rupture and cause heart attacks, according to a new study in Circulation: Research, an American Heart Association journal.</description>
     <link>http://medicalxpress.com/news/2012-03-radioactive-antibody-fragment-scientists-artery.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 29 Mar 2012 16:38:22 EST</pubDate>
	 <guid isPermaLink="false">news252257877</guid>
	 
</item>
<item>
     <title>New study shows promise for developing new treatments for breast cancer</title>
   	 <description>A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as triple-negative breast cancer. This cancer is associated with early metastasis and resistance to chemotherapy and occurs at women at a younger age.</description>
     <link>http://medicalxpress.com/news/2012-03-treatments-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 14 Mar 2012 11:23:53 EST</pubDate>
	 <guid isPermaLink="false">news250943025</guid>
	 
</item>
<item>
     <title>Metastatic breast cancer hitches a free ride from the immune system</title>
   	 <description>Inflammatory breast cancer (IBC) is the most lethal form of breast cancer . It spreads easily through the lymphatic and blood vessels, forming metastasis which can lead to multi-organ failure. New research published in BioMed Central's open access journal Cell Communication and Signaling demonstrates how IBC cells use IL-8, secreted as part of the anti-inflammatory response by a specific set of white blood cells (monocytes), to increase fibronectin expression.</description>
     <link>http://medicalxpress.com/news/2012-02-metastatic-breast-cancer-hitches-free.html</link>
	 <category>Immunology</category>
	 <pubDate>Fri, 10 Feb 2012 05:30:01 EST</pubDate>
	 <guid isPermaLink="false">news248073643</guid>
	 
</item>


</channel>
</rss>
